NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

支架的全球市場 (2021年∼2026年)

Stents Market (2021 - 2026)

出版商 IndustryARC 商品編碼 996438
出版日期 內容資訊 英文 87 Pages
商品交期: 2-3個工作天內
價格
支架的全球市場 (2021年∼2026年) Stents Market (2021 - 2026)
出版日期: 2020年12月01日內容資訊: 英文 87 Pages
簡介

全球支架的市場規模,預計在預測期間內 (2021年∼2026年) 以5.2%的年複合成長率成長,至2026年達到157億9020萬美元。市場主要促進因素,是與生物吸收性血管支架 (BVS)的開發,及與開腹手術比較的經皮冠狀動脈介入治療 (PCI)的優勢等。

在各產品種類中,冠狀動脈支架是最大的市場區隔,另一方面頸動脈支架的需求今後也大幅增大。各材料中,金屬製支架佔大幅佔有率,另一方面預計聚合物制支架也急速成長。各地區中,南北美洲各國佔全球整體的36.76%,不過,在亞太地區各國預期迅速的市場成長。

本報告提供全球支架的市場相關分析,市場基本結構和主要的促進、阻礙因素,整體市場規模趨勢預測,各產品種類、各材料、各地區/主要國家詳細趨勢,資本交易/事業策略的發展情形,主要企業的簡介等資訊彙整,為您概述為以下內容。

目錄

第1章 支架市場:概要

第2章 支架市場:摘要整理

第3章 支架市場:比較分析

  • 產品的互相比較:主要企業的情況
  • 財務分析:主要企業的情況
  • 市場佔有率分析 (以金額為準):主要企業的情況
  • 專利分析:主要企業的情況
  • 價格趨勢分析

第4章 支架市場影響要素

  • 推動市場要素
  • 阻礙市場要素/課題
  • 波特的五力分析
    • 供應商談判力
    • 客戶談判力
    • 新加入企業的威脅
    • 現有企業間的競爭關係
    • 替代產品的威脅

第5章 支架市場:策略分析

  • 價值鏈分析
  • 市場機會分析
  • 產品生命週期

第6章 支架市場:各產品種類 (以金額為準)

  • 冠狀
  • 週邊
  • 膽汁
  • 頸動脈
  • 神經血管
  • 其他

第7章 支架市場:各材料 (以金額為準)

  • 金屬
  • 聚合物
  • 天然

第8章 支架市場:各地區 (以金額為準)

  • 南北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 巴西
    • 其他的南北美洲各國
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 英國
    • 其他的歐洲各國
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區各國
  • 其他的國家 (RoW)
    • 中東
    • 非洲

第9章 支架市場:市場變化的方向性

第10章 支架市場:企業分析

  • Abbott Laboratories
  • B.Braun Melsungen AG
  • Boston Scientific
  • CR Bard Incorporation
  • Cook Medical
  • Medtronic Plc
  • Biotronik
  • Elixir Medical Corporation
  • Stentys
  • Terumo Medical Corporation
目錄
Product Code: HCR 0693

Stents Market Overview

Stents Market size is estimated to reach $15,790.2 million by 2026, growing at a CAGR of 5.2% during the forecast period 2021-2026. A stent is a short mesh tube that acts as a scaffold to help keep the artery open. It restores blood or other fluids, depending on where it is placed. Stent implants are commonly used to treat heart abnormalities such as blocked blood vessels. They are also inserted in the ureter to prevent obstruction of urine from the kidney, in the gall bladder to allow passage of bile in patients, in the abdomen & gastrointestinal tract among others. Stents are in great demand for diseases such as cardiovascular disease in elderly and middle-aged patients. The technological advancements in stents development also play a major role in market growth. The stents now are biodegradable as they completely disappear over time and decrease the risk associated with late stent thrombosis. The increasing prevalence of coronary artery diseases and peripheral artery diseases is estimated to boost the market growth over 2021-2026.

Stents Market Report Coverage

The report: "Stents Market Forecast (2021-2026)", by Industry ARC, covers an in-depth analysis of the following segments of the Stents Market.

  • By Product Type: Coronary, Peripheral, Biliary, Carotid, Neurovascular, and others.
  • By Material: Metallic, Polymer, and Natural.
  • By Geography: Americas, Asia-Pacific, Europe, and Rest of World.

Key Takeaways

  • Geographically, the Americas region is poised to see extraordinary development owing to the minimally invasive surgeries and increasing the population of the people suffering from CVD that requires stenting procedures in the region.
  • Based on Product type, the Coronary segment is gaining demand owing to the high prevalence of cardiovascular diseases coupled with the growing technological advancements in coronary stents.
  • The lack of large-scale availability of advanced surgical equipment and skilled personnel in underdeveloped economies and developing economies is estimated to restrain the market growth during the forecast period 2021-2026.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Stents Market report.

Stents Market Segment Analysis - By Product Type

The global Stents Market based on Product Type can be further segmented into Coronary, Peripheral, Biliary, Carotid, Neurovascular, and others. The Coronary Stent segment is the major segment generating revenue in 2020. This is owing to the high prevalence of cardiovascular diseases coupled with the growing technological advancements in coronary stents. The Carotid stent segment is estimated to register the fastest CAGR of 9.2% during the forecast period 2021-2026. This is owing to the rise in the prevalence of disorders such as ischemic stroke, peripheral vascular lesions leading the increasing demand of Carotid Stents in coming years.

Stents Market Segment Analysis - By Material

The global Stents Market based on Material can be further segmented into Metallic, Polymer, and Natural. The Metallic segment registers for the highest market share in 2020. This is owing to the increasing demand for metallic stents across the globe. In addition, they lower the risk of restenosis and the other complications. Moreover, usage of bioresorbable metal vascular stents is increasing owing to its presence of alloys that degrades safely within the body. The Polymer segment is estimated to register the fastest CAGR for the period 2021-2026. This is owing to its cost-effectiveness. Furthermore, the use of non-metallic long-term stents for ureteral obstruction is driving the demand.

Stents Market Segment Analysis - By Geography

The global Healthcare Regulatory Affairs Outsourcing Market based on Geography, can be further segmented into the Americas, Asia-Pacific, Europe, and Rest of World. Americas registered for the highest revenue share of 36.76% globally in 2020 owing to the minimally invasive surgeries and increasing the population of the people suffering from CVD and other high-risk factor requiring stenting procedures. In addition, technological advancements in stent technologies during the past three decades, such as bifurcated stents and the use of biodegradable materials, have further augmented market growth. However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR during the forecast period 2021-2026 owing to the increasing usage of vascular stents for cardiovascular diseases, the introduction of new and cost-effective stents by the key players in this region.

Stents Market Drivers

Development of Bioresorbable Vascular Scaffolds (BVS)

Traditional stents manufactured from metal mesh remain permanently in the body or unless removed through surgical intervention but bioresorbable vascular scaffolds are biodegradable, therefore, they completely disappear over time, additionally, and the risk of the restenosis using metallic stents and the drug-eluting stent has elevated the need for bioabsorbable stents thereby driving the market. BVS drug elution avoids non-intimal proliferation compared to drug-eluting stents, and complete bio-resorption is consistent with late vessel lumen enlargement, plaque regression, and vasomotion, owing to which BVS is set to boost the market growth during the forecast period 2021-2026.

Shorter Recovery Time as Compared to Open-Heart Surgery

The recovery time for Percutaneous Coronary Intervention (PCI) is significantly less than the by-pass surgeries. It takes only a few days to recover from stenting, whereas bypass surgery takes more than six weeks or even longer to recover from it, which is likely to fuel the market growth. PCI can be performed in a shorter interval of time than the by-pass surgery as the stent is inserted into the body from the groin area or arm through a catheter. Owing to the lesser recovery time and in-hospital time, the adoption of stents for cardiovascular diseases is set to grow at a healthy rate for the period 2021-2026.

Stents Market Challenges

Requirement of Advanced Surgical Equipment Along with Skilled Medical Personnel

The PCI technique requires skilled surgeons for the placement of the stent at the required location. Moreover, it also requires advanced devices such as atherectomy devices, Fractional Flow Reserve, Intravascular Ultrasound, Optical Coherence Tomography (OCT) Imaging, Near-Infrared Spectroscopy (NIRS) to transfer the stent to the target site. Thus, skilled medical personnel is required to operate the equipment and surgeons to perform the procedure. The lack of large-scale availability of such equipment and skilled personnel in underdeveloped economies and developing economies is set to hinder the market growth during the period 2020-2026.

Stents Market Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Stents Market. Key companies of this market include Abbott Laboratories, B.Braun Melsungen AG, Boston Scientific, C.R Bard Incorporation, Cook Medical, Medtronic Plc, Biotronik, Elixir Medical Corporation, Stentys, and Terumo Medical Corporation.

Acquisitions/Product Launches:

  • In July 2020, Biotronik has announced its next-generation balloon-expandable cobalt-chromium lilac stent system which is thinner, stronger and more flexible when compared to leading competitors.
  • In June 2020, BD announced the acquisition of Straub Medical AG. This acquisition helped BD to enhance its product portfolio of stents.
  • In February 2019, Medtronic plc has the launch of the Valiant Navion thoracic stent graft system in Japan for the minimally invasive repair of thoracic descending aortic aneurysms (TAA) and complicated type B aortic dissections (TBAD).

Table of Contents

1. Stents Market- Overview

  • 1.1 Definitions and Scope

2. Stents Market- Executive Summary

  • 2.1 Market Revenue, Market Size and Key Trends
  • 2.2 Key trends by Product Type
  • 2.3 Key trends by Geography

3. Stents Market - Comparative Analysis

  • 3.1 Product Benchmarking - Key Companies
  • 3.2 Financial Analysis - Key Companies
  • 3.3 Market Value Split by Key Companies
  • 3.4 Patent Analysis - Key Companies
  • 3.5 Pricing Analysis

4. Stents Market Forces

  • 4.1 Market Drivers
  • 4.2 Market Constraints/Challenges
  • 4.3 Porters five force model
    • 4.3.1 Bargaining power of suppliers
    • 4.3.2 Bargaining powers of customers
    • 4.3.3 Threat of new entrants
    • 4.3.4 Rivalry among existing players
    • 4.3.5 Threat of substitutes

5. Stents Market - Strategic Analysis

  • 5.1 Value Chain Analysis
  • 5.2 Opportunities Analysis
  • 5.3 Market Life Cycle

6. Stents Market - By Product Type (Market Size - $Million/$Billion)

  • 6.1 Coronary
  • 6.2 Peripheral
  • 6.3 Biliary
  • 6.4 Carotid
  • 6.5 Neurovascular
  • 6.4 Others

7. Stents Market - By Material (Market Size - $Million/$Billion)

  • 7.1 Metallic
  • 7.2 Polymer
  • 7.3 Natural

8. Stents Market - By Geography (Market Size - $Million/$Billion)

  • 8.1 Americas
    • 8.1.1 U.S.
    • 8.1.2 Canada
    • 8.1.3 Mexico
    • 8.1.4 Brazil
    • 8.1.5 Rest of Americas
  • 8.2 Europe
    • 8.2.1 Germany
    • 8.2.2 France
    • 8.2.3 Italy
    • 8.2.4 Spain
    • 8.2.5 Russia
    • 8.2.4 U.K.
    • 8.2.5 Rest of Europe
  • 8.3 Asia-pacific
    • 8.3.1 China
    • 8.3.2 India
    • 8.3.3 Japan
    • 8.3.4 South Korea
    • 8.3.5 Rest of Asia-Pacific
  • 8.4 Rest of the World
    • 8.4.1 Middle East
    • 8.4.2 Africa

9. Stents Market - Entropy

10. Stents Market Company Analysis

  • 10.1 Abbott Laboratories
  • 10.2 B.Braun Melsungen AG
  • 10.3 Boston Scientific
  • 10.4 C.R Bard Incorporation
  • 10.5 Cook Medical
  • 10.4 Medtronic Plc
  • 10.5 Biotronik
  • 10.6 Elixir Medical Corporation
  • 10.9 Stentys
  • 10.10 Terumo Medical Corporation